Navigation Links
An international study in China finds strawberries may slow precancerous growth in the esophagus
Date:4/6/2011

COLUMBUS, Ohio Eating strawberries may be a way to help people at risk of esophageal cancer protect themselves from the disease, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC James) and researchers in China.

Dr. Tong Chen will present the findings during a press briefing at 8 a.m. April 6 at the American Association for Cancer Research (AACR) 102nd meeting 2011 in Orlando, Fla. The study is the first-ever collaborative Ohio State cancer clinical trial to be conducted in China.

"We concluded from this study that six months of strawberry treatment is safe and easy to consume. In addition, our preliminary data suggests that strawberries decreased histological grade of precancerous lesions and reduced cancer-related molecular events," said Chen, lead author, and assistant professor in the division of medical oncology, department of internal medicine at Ohio State. She is also a member of the Molecular Carcinogenesis and Chemoprevention program in Ohio State's Comprehensive Cancer Center.

Previously published research by Chen and colleagues found that freeze-dried strawberries significantly inhibited tumor development in the esophagus of rats. Based on these results, the researchers embarked on a phase Ib clinical trial in China to investigate the effects of freeze-dried strawberries on patients with esophageal precancerous lesions.

"We found that daily consumption of strawberries suppressed various biomarkers involved in esophageal carcinogenesis, including cell proliferation, inflammation and gene transcription," Chen said.

Each of the 36 study participants ate 60 grams (about two ounces) of freeze-dried strawberries daily for six months. The researchers obtained biopsy specimens before and after the strawberry consumption. The results showed that 29 out of 36 participants experienced a decrease in histological grade of the precancerous lesions during the study.

"We predict that the majority of patients with precancerous lesions in their esophagus will develop esophageal cancer over subsequent decades," said Chen. "Our study is important because it shows that strawberries may slow the progression of precancerous lesion in the esophagus. Strawberries may be an alternative, or may work together with other chemopreventive drugs, for the prevention of esophageal cancer. But, we will need to test this in randomized placebo-controlled trials in the future."

Esophageal cancer is the third most common gastrointestinal cancer and the sixth most frequent cause of cancer death in the world, said Chen, who also holds a doctorate in Public Health. Chen and her team are studying esophageal squamous cell carcinoma which makes up 95 percent of cases of esophageal cancer worldwide. The survival rate of this type of esophageal cancer is very low, with only 10 percent of patients living 5 years after diagnosis.

Esophageal squamous cell carcinoma is quite common in China, Japan, the Transkei region of South Africa, Iran, France and Puerto Rico.

"Since this clinical trial is being conducted in China, considerably more effort is required to establish and complete the trial than is typically necessary at our own institution. Nevertheless, we have established a team of highly collaborative investigators who are working well together," said Chen.

China has the largest population in the world, and the number of potential participants for clinical trials is higher than in any other country in the world.

"We believe that establishing collaborative research teams will enhance clinical research, and that our project will 'open doors' for multiple other trials in China," Chen said.

In the United States, Canada and Europe, the risk factors for developing esophageal cancer include tobacco and alcohol use, along with poor diet lacking fruits and vegetables.

In Asia, additional risk factors include dietary intake of salty food and of food contaminated with various mycotoxins, deficiencies in dietary vitamins and minerals and thermal injuries due to the consumption of hot beverages.

More than 16,000 new cases of esophageal cancer will be diagnosed in the United States this year, according to the American Cancer Society.


'/>"/>

Contact: Eileen Scahill
Eileen.Scahill@osumc.edu
614-293-3737
Ohio State University Medical Center
Source:Eurekalert

Related medicine news :

1. EPIDEMICS(3) The Third International Conference on Infectious Disease Dynamics
2. 2nd International Conference on Immune Tolerance
3. International Diabetes Federation supports surgery to treat diabetes
4. International Open Access meeting comes to the United States
5. ICUROS study finds international variations in quality of life loss after fracture
6. Clinical trial for dry mouth funded by international oral care award
7. Minnesota House of Representatives passes 2011 International Year of Chemistry Resolution
8. International Liver Congress 2011
9. Report: International collaboration between researchers results in greater recognition
10. International panel revises McDonald Criteria for diagnosing multiple sclerosis
11. International collaborative identifies 13 new heart-disease-associated gene sites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... of Australia,s successful biotechnology scientists, Dr ... company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is ... the ASX. Noxopharm is a clinic-ready company with its ... clinical study later this year. ... facing cancer patients - the ability of cancers to become resistant ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: